PRospect trial to elucidate the utility of EchocarDIography-based Cardiac ouTput in acute heart failure (PREDICT) study

PRospect trial to elucidate the utility of EchocarDIography-based Cardiac ouTput in acute heart failure (PREDICT) study - PREDICT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039687

Enrollment

430

Registered

2020-04-01

Start date

2019-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult patients who will admit to the 16 participating hospitals due to worsening heart failure diagnosed based on Framingham criteria from January 2019 to September 2020 will be enrolled.

Exclusion criteria

Exclusion criteria: Patients with acute coronary syndrome, those need for hemodialysis, and those who had been already received positive inotropic agents before the index echocardiography.

Design outcomes

Primary

Measure	Time frame
Worsening heart failure defined as need for initiation of positive inotropic agents within 7 days after the admission	—

Secondary

Measure	Time frame
Worsening renal function defined as an increase in serum creatinine of 0.3 mg/dL during the treatment, time duration for bed rest, inhospital duration, and all cause mortality during the hospital treatment.	—

Countries

Japan

Contacts

Public ContactHiroyuki Iwano

Faculty of Medicine and Graduate School of Medicine, Hokkaido University Department of Cardiovascular Medicine

h-iwano@med.hokudai.ac.jp011-706-6973

Outcome results